RECRUITINGOBSERVATIONAL
A Registered Cohort Study on SMA
A Registered Cohort Study on Spinal Muscular Atrophy
About This Trial
Spinal muscular atrophy (SMA) is an autosomal recessive disease that causes progressive muscle wasting and weakness due to loss of motor neurons in the spinal cord. This is a registered cohort of spinal muscular atrophy (SMA) type I，II and III in China. This study will provide further insights into the clinical course of SMA including overall survival, demographic characteristics, motor function, respiratory support, feeding and nutritional support, growth and development. The correlation of genotype and phenotype will be conducted.
Who May Be Eligible (Plain English)
Who May Qualify:
- Patients with SMA types I, II and III
- Asymptomatic SMA carriers
- Relatives of SMA patients or carriers
- Unrelated healthy controls
- Participants or Parent(s)/legal guardian(s) willing and able to complete the willing to sign a consent form process
Who Should NOT Join This Trial:
\* Participants are unable to comply with trial procedures and visit schedule
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Patients with SMA types I, II and III
* Asymptomatic SMA carriers
* Relatives of SMA patients or carriers
* Unrelated healthy controls
* Participants or Parent(s)/legal guardian(s) willing and able to complete the informed consent process
Exclusion Criteria:
\* Participants are unable to comply with trial procedures and visit schedule
Locations (1)
Department of Neurology, First Affiliated Hospital Fujian Medical University
Fuzhou, Fujian, China